Case Studies Antabio Implement Web-based Informatics Solution to Facilitate Global Collaborations

Edit This Case Study Record

	Antabio Implement Web-based Informatics Solution to Facilitate Global Collaborations

Antabio Implement Web-based Informatics Solution to Facilitate Global Collaborations

Technology Category	Application Infrastructure & Middleware - Data Visualization Platform as a Service (PaaS) - Data Management Platforms
Applicable Industries	Healthcare & Hospitals Pharmaceuticals
Applicable Functions	Product Research & Development
Services	Data Science Services
Challenge	Antabio, a biopharmaceutical company, was initially a small start-up with a single program in the hit to lead phase. As the company expanded, the scientists were making more molecules and introducing different assays. They were using a simple chemistry enabled database to associate structures and data. However, they quickly became frustrated with the time taken to analyze data, risks inherent in manual data manipulations, inability to capture or link the data to the raw data and parameters of the assays, lack of ability to follow any variations in assay protocols, and lack of project oversight. Read More
About Customer	Antabio is a private biopharmaceutical company that is developing a broad pipeline of novel antibacterial treatments focused on drug-resistant life-threatening infections. All of Antabio's programs address WHO critical priority pathogens and are eligible for streamlined development. The company was founded in 2009 by Marc Lemonnier and has built a best-in-class, international team with highly successful track records including former executives from Novexel, Galapagos, Merck, GSK, and Astra Zeneca. The company is headquartered near Toulouse, France and has UK and US subsidiaries. Read More
Solution	Antabio decided on a web-based informatics system to facilitate collaborating with colleagues across the globe in addition to CRO partners. Access to all scientific experiments, data, and knowledge was a priority for their project progression decisions. After a full review of the market, Antabio chose the Dotmatics solution in 2014 and, with the help of the implementation team, configured the system to cover key areas such as assay data, IC50 and KI results directly from enzyme assays, MICs, bacterial susceptibility, plate set-up for which is non-standard and complex, project overview, and analytics with Browser and Vortex. Read More Log in to view content
Contents

Technology Category

Application Infrastructure & Middleware - Data Visualization

Platform as a Service (PaaS) - Data Management Platforms

Applicable Industries

Healthcare & Hospitals

Pharmaceuticals

Applicable Functions

Product Research & Development

Services

Data Science Services

Challenge

Antabio, a biopharmaceutical company, was initially a small start-up with a single program in the hit to lead phase. As the company expanded, the scientists were making more molecules and introducing different assays. They were using a simple chemistry enabled database to associate structures and data. However, they quickly became frustrated with the time taken to analyze data, risks inherent in manual data manipulations, inability to capture or link the data to the raw data and parameters of the assays, lack of ability to follow any variations in assay protocols, and lack of project oversight.

About Customer

Antabio is a private biopharmaceutical company that is developing a broad pipeline of novel antibacterial treatments focused on drug-resistant life-threatening infections. All of Antabio's programs address WHO critical priority pathogens and are eligible for streamlined development. The company was founded in 2009 by Marc Lemonnier and has built a best-in-class, international team with highly successful track records including former executives from Novexel, Galapagos, Merck, GSK, and Astra Zeneca. The company is headquartered near Toulouse, France and has UK and US subsidiaries.

Solution

Antabio decided on a web-based informatics system to facilitate collaborating with colleagues across the globe in addition to CRO partners. Access to all scientific experiments, data, and knowledge was a priority for their project progression decisions. After a full review of the market, Antabio chose the Dotmatics solution in 2014 and, with the help of the implementation team, configured the system to cover key areas such as assay data, IC50 and KI results directly from enzyme assays, MICs, bacterial susceptibility, plate set-up for which is non-standard and complex, project overview, and analytics with Browser and Vortex.

Impact #1	Scientists at Antabio are now able to see all data necessary for making project progression decisions and senior management have up to date information for accurate planning.
Impact #2	Researchers no longer have the burden of moving data about between systems with the inherent risks of propagating errors.
Impact #3	Scientists can spend more of their time analyzing results and making judgements on the quality and acceptability of data rather than on data manipulation.

Impact #1

Scientists at Antabio are now able to see all data necessary for making project progression decisions and senior management have up to date information for accurate planning.

Impact #2

Researchers no longer have the burden of moving data about between systems with the inherent risks of propagating errors.

Impact #3

Scientists can spend more of their time analyzing results and making judgements on the quality and acceptability of data rather than on data manipulation.

Download PDF Version

Overview

Antabio Implement Web-based Informatics Solution to Facilitate Global Collaborations

Operational Impact